Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To estimate the prevalence of EGFR mutation in a representative sample of patients with newly diagnosed stage IIIB/IV NSCLC in Spain (predominantly Caucasian ethnicity).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To estimate the prevalence of EGFR mutation in a representative sample of patients with newly diagnosed stage IIIB/IV NSCLC in Spain (predominantly Caucasian ethnicity). |
| Measure | Description | Time Frame |
|---|---|---|
| Correlate EGFR mutation status with clinico-pathological characteristics. The study will aim to determine the prevalence of EGFR M+ lung cancers in patients with clinico-pathological characteristics not commonly associated with EGFR mutation positivity | ||
| To describe different EGFR mutation methods used in Spain and testing turn around time associated |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
To be recruited by Oncologist
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Carmen Gonzalez Arenas | Medical Department. Mediclin-AstraZeneca. Spain | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Santiago de Compostela | A Coruna | Spain | |||
| Research Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25766256 | Derived | Esteban E, Majem M, Martinez Aguillo M, Martinez Banaclocha N, Domine M, Gomez Aldaravi L, Juan O, Cajal R, Gonzalez Arenas MC, Provencio M. Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study. Cancer Epidemiol. 2015 Jun;39(3):291-7. doi: 10.1016/j.canep.2015.02.003. Epub 2015 Mar 9. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| To determine the % of confirmed stage IIIB/IV NSCLC patients who cannot be tested for EGFR mutation and the reasons for not testing (% of EGFR Mnt) |
| Albacete |
| Albacete |
| Spain |
| Research Site | Alicante | Alicante | Spain |
| Research Site | Elche | Alicante | Spain |
| Research Site | Barcelona | Barcelona | Spain |
| Research Site | Cáceres | Caceres | Spain |
| Research Site | Santander | Cantabria | Spain |
| Research Site | Córdoba | Cordoba | Spain |
| Research Site | Girona | Girona | Spain |
| Research Site | Granada | Granada | Spain |
| Research Site | Jaén | Jaen | Spain |
| Research Site | Lugo | Lugo | Spain |
| Research Site | Madrid | Madrid | Spain |
| Research Site | Málaga | Malaga | Spain |
| Research Site | Murcia | Murcia | Spain |
| Research Site | Pamplona | Navarre | Spain |
| Research Site | Pontevedra | Pontevedra | Spain |
| Research Site | Vigo | Pontevedra | Spain |
| Research Site | Oviedo | Principality of Asturias | Spain |
| Research Site | Salamanca | Salamanca | Spain |
| Research Site | Seville | Sevilla | Spain |
| Research Site | Reus | Tarragona | Spain |
| Research Site | Valencia | Valencia | Spain |
| Research Site | Zaragoza | Zaragoza | Spain |
| ID | Term |
|---|---|
| D002289 | Carcinoma, Non-Small-Cell Lung |
| ID | Term |
|---|---|
| D002283 | Carcinoma, Bronchogenic |
| D001984 | Bronchial Neoplasms |
| D008175 | Lung Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided